Cutaneous Melanoma — Trials

Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

241 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 78
Recruiting: 39
Ph III recruiting: 3
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.1%
Trials / 1,000 deaths: 9.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07576725	Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial	not yet recruiting	Phase 2	50	Fred Hutchinson Cancer CenterOTHER	1	Sep 17, 2026	clinicaltrials
NCT07807878	Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma(BAP1treat)	not yet recruiting	Phase 2	28	Assistance Publique Hopitaux De MarseilleOTHER	0	Sep 8, 2026